Evidence map›Paper›PMID 36125266›Full record

ArticleMicrobiology spectrum2022

Back to the Origin:

Sana Ncir, Agnese Lupo, Antoine Drapeau, Pierre Châtre, Meriem Souguir, Sana Azaiez, Jean-Yves Madec, Wejdene Mansour, Marisa Haenni

Open access · goldAbstract readLetter
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sana NcirUnité Antibiorésistance et Virulence Bactériennes, ANSES - Université de Lyon, Lyon, France.
Agnese LupoUnité Antibiorésistance et Virulence Bactériennes, ANSES - Université de Lyon, Lyon, France.
Antoine DrapeauUnité Antibiorésistance et Virulence Bactériennes, ANSES - Université de Lyon, Lyon, France.
Pierre ChâtreUnité Antibiorésistance et Virulence Bactériennes, ANSES - Université de Lyon, Lyon, France.
Meriem SouguirUnité Antibiorésistance et Virulence Bactériennes, ANSES - Université de Lyon, Lyon, France.
Sana AzaiezLaboratoire de Biophysique métabolique et Pharmacologie Appliquée (LR12ES02), Faculté de Médecine Ibn Al Jazzar Sousse, Sousse, Tunisia.
Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes, ANSES - Université de Lyon, Lyon, France.
Wejdene MansourLaboratoire de Biophysique métabolique et Pharmacologie Appliquée (LR12ES02), Faculté de Médecine Ibn Al Jazzar Sousse, Sousse, Tunisia.
Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, ANSES - Université de Lyon, Lyon, France.ORCID 0000-0003-1333-5603
Université Claude Bernard Lyon 1 · FRUniversity of Sousse · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ShewanellaAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsMicrobial Sensitivity TestsRiversAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesCarbapenemscarbapenemIS91NDM-1OXA-204PER-1Shewanella bicestriiShewanella xiamenensisTunisia

Identifiers

PMID36125266
PMCPMC9604219
OpenAlexW4296781884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.